参考文献/References:
[1] Speiser PW,Arlt W,Auchus RJ,et al.Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline [J].J Clin Endocrinol Metab,2018,103(11):4043-4088.DOI:10.1210/jc.2018-01865.
[2] 中华医学会儿科学分会内分泌遗传代谢病学组.先天性肾上腺皮质增生症21-羟化酶缺陷诊治共识[J].中华儿科杂志,2016,54(8):569-576.DOI:10.3760/cma.j.issn.0578-1310.2016.08.003.
[3] Nordenström A,Falhammar H.Management of endocrine disease:diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency [J].Eur J Endocrinol,2019,180(3):R127-R145.DOI:10.1530/eje-18-0712.
[4] Gaudl A,Kratzsch J,Ceglarek U.Advancement in steroid hormone analysis by LC-MS/MS in clinical routine diagnostics - A three year recap from serum cortisol to dried blood 17α-hydroxyprogesterone [J].J Steroid Biochem Mol Biol,2019,192:105389.DOI:10.1016/j.jsbmb.2019.105389.
[5] Turpeinen U,Itkonen O,Ahola L,et al.Determination of 17alpha-hydroxyprogesterone in serum by liquid chromatography-tandem mass spectrometry and immunoassay [J].Scand J Clin Lab Invest,2005,65(1):3-12.DOI:10.1080/00365510410008421.
[6] Ray JA,Kushnir MM,Yost RA,et al.Performance enhancement in the measurement of 5 endogenous steroids by LC-MS/MS combined with differential ion mobility spectrometry [J].Clin Chim Acta,2015,438:330-336.DOI:10.1016/j.cca.2014.07.036.
[7] Etter ML,Eichhorst J,Lehotay DC.Clinical determination of 17-hydroxyprogesterone in serum by LC-MS/MS:comparison to Coat-A-Count RIA method [J].J Chromatogr B Analyt Technol Biomed Life Sci,2006,840(1):69-74.DOI:10.1016/j.jchromb.2006.04.038.
[8] Meng L,Su S,Li L,et al.Delivery prediction by quantitative analysis of four steroid metabolites with liquid chromatography tandem mass spectrometry in asymptomatic pregnant women [J].Ann Med,2022,54(1):1150-1159.DOI:10.1080/07853890.2022.2067895.
[9] 国家卫生健康委临床检验中心新生儿遗传代谢病筛查室间质评委员会.新生儿先天性肾上腺皮质增生症筛查与诊断实验室检测技术专家共识[J].中华检验医学杂志,2019,42(12):1014-1019.DOI:10.3760/cma.j.issn.1009-9158.2019.12.008.
[10] 中华医学会儿科分会罕见病学组,中国医师协会医学遗传医师分会,中国妇幼保健协会出生缺陷防治与分子遗传分会,等.21羟化酶缺陷导致的先天性肾上腺皮质增生症的实验室诊断共识[J].中华医学遗传学杂志,2023,40(7):769-780.DOI:10.3760/cma.j.cn511374-20230330-00178.
[11] Livadas S,Dracopoulou M,Dastamani A,et al.The spectrum of clinical,hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene [J].Clin Endocrinol(Oxf),2015,82(4):543-549.DOI:10.1111/cen.12543.
[12] Claahsen-van der Grinten HL,Speiser PW,Ahmed SF,et al.Congenital adrenal hyperplasia-current insights in pathophysiology,diagnostics,and management [J].Endocr Rev,2022,43(1):91-159.DOI:10.1210/endrev/bnab016.
[13] Miller WL.The syndrome of 17,20 lyase deficiency [J].J Clin Endocrinol Metab,2012,97(1):59-67.DOI:10.1210/jc.2011-2161.
[14] Nimkarn S,New MI.Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia [J].Trends Endocrinol Metab,2008,19(3):96-99.DOI:10.1016/j.tem.2008.01.002.
[15] Krone N,Dhir V,Ivison HE,et al.Congenital adrenal hyperplasia and P450 oxidoreductase deficiency [J].Clin Endocrinol(Oxf),2007,66(2):162-172.DOI:10.1111/j.1365-2265.2006.02740.x.
[16] Ye L,Zhao Z,Ren H,et al.A multiclassifier system to identify and subtype congenital adrenal hyperplasia based on circulating steroid hormones [J].J Clin Endocrinol Metab,2022,107(8):e3304-e3312.DOI:10.1210/clinem/dgac271.
[17] Chen HD,Huang LE,Zhong ZH,et al.Ovarian adrenal rest tumors undetected by imaging studies and identified at surgery in three females with congenital adrenal hyperplasia unresponsive to increased hormone therapy dosage [J].Endocr Pathol,2017,28(2):146-151.DOI:10.1007/s12022-016-9461-4.
[18] Tsai WH,Wong CH,Dai SH,et al.Adrenal tumor mimicking non-classic congenital adrenal hyperplasia [J].Front Endocrinol(Lausanne),2020,11:526287.DOI:10.3389/fendo.2020.526287.
[19] Wong FCK,Chan AZ,Wong WS,et al.Hyperandrogenism,elevated 17-hydroxyprogesterone and its urinary metabolites in a young woman with ovarian steroid cell tumor,not otherwise specified:case report and review of the literature [J].Case Rep Endocrinol,2019,2019:9237459.DOI:10.1155/2019/9237459.
[20] Lu Y,Wang E,Chen Y,et al.Obesity-induced excess of 17-hydroxyprogesterone promotes hyperglycemia through activation of glucocorticoid receptor [J].J Clin Invest,2020,130(7):3791-3804.DOI:10.1172/JCI134485.